SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
Search for another company:
ALL
Korea
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).

MEDIFRON DBT CO.,LTD.

Main Activities: Electrical and Electronic Goods Merchant Wholesalers

facebook Please check the full coverage of information what EMIS can offer you. SEE SAMPLE

Company Information

Full name
MEDIFRON DBT CO.,LTD.

Headquarters
RM.1401,A-DONG,WOORIM BLUE NINE BUSINESS CENTER,24, 0-21, YEOMCHANG-DONG, GANGSEO-GU, SEOUL; Seoul; Seoul; 157861
Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
Financial Auditors: SINHAN (2011)
Incorporation Date: March 18, 1997
Total Employees: 25

Tel: 02-545-9277

Company Description

Despite sluggish contents biz, firms sales rose YoY, because of favorable tune in IT distribution sector including monitors, and new sales of new drugs including pain killer.Net profit turned into surplus, in view of cost ratio decline including high margin goods sales, and elimination of loss on equity method related to Digital Biotech in the first half.The firm has R&D network equipped with global competitiveness, owing to technology transfer of neural pain treatment drug and dementia drug to Grudental
More

Company Analysis

According to the Individual - Audited financial statement for the first half of 2012, total net operating revenues decreased with -22.73%, from KRW 6,107,707 thousands to KRW 4,719,174 thousands. Operating Results decreased from KRW 170,418 thousands to KRW -1,447,583 thousands. The results of the period reached KRW -1,452,892 thousands at the end of the period against KRW 176,718 thousands last year. Return on equity (Net income/Total equity) went from 0.46% to -4.00%, the Return On Asset (Net income / Total Asset) went from 0.43% to -3.89% and the Net Profit Margin (Net Income/Net Sales) went from 2.89% to -30.79% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 2.69% compared to 7.68% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 4.63 to 32.94 when compared to the previous year.

Key Executives

Kim,Yeong Ho President
Muk,Hyeon Sang President
Kim,Jong Mo Non-Executive Independent Director
Sin,Seong Jun Auditor
Im,Dong Beom Executive Director
More

Companies with Similar Main Activities

ISI Emerging Markets

FULL COMPANY PROFILE

Please check the full coverage of information what EMIS can offer you.
SEE SAMPLE
SELECT CURRENCY
Balance Sheet

Total Assets

37,325,001

38,643,828

Current Assets

9,426,090

10,706,101

Total Liabilities

977,110

843,044

Shareholders Equity

36,347,892

37,800,784

Current Liabilities

286,168

423,012

* All the accounts are in KRW.
Income Statement

Total Operating Revenue

4,719,174

13,231,774

Operational Profit (Loss)

-1,447,583

681,143

Net Profit (Loss)

-1,452,892

684,158

* All the accounts are in KRW.
Ratios
Profitability Ratios

Return on Assets (ROA)

-3.89%

1.77%

Return on Equity (ROE)

-4%

1.81%

Return on Sales (ROS)

-30.79%

5.17%

Return on Capital

-3.92%

1.79%

Gross Profit Margin

-7.78%

19.12%

Efficiency Ratios

Current asset turnover

0.50x

1.24x

Asset Turnover

0.13x

0.34x

Valuation figures and ratios

Earning Before Interests and Taxes (EBIT)

-1,452,892

452,676

EBITDA

-1,436,065

704,144

Bookvalue (BV)

8,785,135

10,241,808

Liquidity Ratios

Current Ratio

3,293.9%

2,530.92%

Quick ratio

2,565.19%

1,838.51%

Doom's day ratio

859.88%

693.91%

Cash Flow to Debt

-48.57%

-14.66%

Leverage Ratios

Leverage ratio

102.69%

102.23%

Interest Coverage Ratio

0%

397.64%

Debt to equity

2.69%

2.23%

Debt to total assets

2.62%

2.18%

Long Term Debt to Capital

1.87%

1.1%

Market ratios

Price/Book Ratio

4.29

5.38

Trend Ratios

Revenue Trend

77.27%

107.95%

Net Income Trend

-822.15%

-28.48%